Systemic effects of inflammation on health during chronic HIV infection
about
The gut microbiome in human immunodeficiency virus infectionAnimal Models for HIV Cure ResearchAnimal models in HIV cure researchPatient-centered care for people living with multimorbidityLoss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus MacaquesAdipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV InfectionUntangling the Gordian knot of HIV, stress, and cognitive impairmentChanges in Follicular CD4+ T Helper Cells as a Marker for Evaluating Disease Progression in the Competition between HIV and Host ImmunityNeurological immune reconstitution inflammatory response: riding the tide of immune recoveryHIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional studyAntibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed MacaquesEffects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized TrialBidirectional Relationships Between Fatigue and Everyday Experiences in Persons Living With HIV.Predictors of willingness to use a smartphone for research in underserved persons living with HIV.Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.Factors associated with siman immunodeficiency virus transmission in a natural African nonhuman primate host in the wild.HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.Pathogenic features associated with increased virulence upon Simian immunodeficiency virus cross-species transmission from natural hosts.Elevated Spontaneous Interferon-γ Secretion in Human Immunodeficiency Virus-Infected PersonsProgressive proximal-to-distal reduction in expression of the tight junction complex in colonic epithelium of virally-suppressed HIV+ individuals.The Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated Macrophages.Immunologic strategies for HIV-1 remission and eradication.Evolving character of chronic central nervous system HIV infection.Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections.A history of alcohol dependence augments HIV-associated neurocognitive deficits in persons aged 60 and older.KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trial.Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulationObservational research on NCDs in HIV-positive populations: conceptual and methodological considerations.Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study.Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy.HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.Using the pathogenic and nonpathogenic nonhuman primate model for studying non-AIDS comorbidities.Investigating the role of ankyrin-rich membrane spanning protein in human immunodeficiency virus type-1 Tat-induced microglia activation.Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals.Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy.Elevated Biomarkers of Inflammation and Coagulation in Patients with HIV Are Associated with Higher Framingham and VACS Risk Index Scores.Dysregulated Immune Activation in Second-Line HAART HIV+ Patients Is Similar to That of Untreated Patients.Myocardial Infarction, Stroke, and Mortality in cART-Treated HIV Patients on StatinsComplexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy.
P2860
Q26743543-286D4528-3FC2-4A5D-B8B5-C6B1FF358136Q26767476-E940F9FA-79AF-4061-AA0D-D3F323B46824Q26853069-8B348AC8-DEDC-4B44-B557-8FBA5F775743Q27000743-9036F280-8161-4D18-BBFC-EC1D82683FE4Q27316093-DF030067-02EF-4905-AEE7-918E5E1CDE91Q27317216-A23BF6CE-E184-4969-ABC7-EDD39FAB2AE7Q28067483-59241423-8A68-408F-A731-A5E4F0EA0DB5Q28075718-F2AEA201-994D-418D-98DC-EE17BA0F09D6Q28082309-E62920EC-9AA4-466B-95C8-B6268611D653Q28539550-283392C9-BAF6-4DCB-A256-B1E8406B5555Q28552448-ED086578-962E-4E22-821E-56BCBB7B6DB8Q28552729-A96D77AD-5F35-4330-8E0D-D451D12917C6Q33448114-E493EF0D-A210-400C-9E29-F1E4A7ACA2DBQ33452454-3E4E35A9-72DA-45C1-905C-5BCEA06CDBB7Q33585386-47CAC017-65B4-417B-99E1-27FE0AE0F3ADQ33602718-DA2D6AFD-3466-4D8B-8FA7-EBB712A1ABBBQ33618542-045E9D4C-0905-47E0-9F8E-51F8ED3D081AQ33743884-322EFEFD-CED5-4796-A169-4773BFD39053Q33772397-CCE8109E-5DFA-4102-BACD-AEC31D93DF49Q33812820-5EC13586-54F7-4CBB-B5AF-133A87168FC0Q33884876-666C3981-1A06-48F3-AE70-A80E4D59187FQ33896523-A99F7D47-18AF-4C6B-B23E-C5E724122412Q33995713-6D65EC2B-63C9-4AFF-BC45-74A9851A65FCQ34082628-26AAE440-05A7-4221-943D-16E09FC57420Q34388983-07254073-90A7-4ECD-9EAA-1A80C3EE9AEDQ34417383-071909E8-A703-4857-BA14-3F04891B6FDCQ34812071-A304693F-FE97-40BA-B2C6-6474B3E9BAC0Q35021902-B9ED3111-1A14-4643-9D38-F93A2A409437Q35049714-48470514-67A5-4F84-8945-EC7A0D2C5139Q35109483-F773F384-DFE1-4118-B27E-0387C0E56B4AQ35146687-9015C7B3-1BCB-422C-A1B1-148042688920Q35156136-B4BB1746-6645-4F8B-8967-F4399CC3B93EQ35204909-1953B1BD-732B-4758-91D9-C478E8D25065Q35220407-88742D63-4668-43ED-8909-126C02B7D345Q35434347-0F15460B-81DA-4379-86FE-475C820A5282Q35582240-30781D92-7F38-49BB-9A6B-98E05903DD87Q35862321-53D3A94F-042A-4F09-AD85-50C8795FB3ABQ35873402-3C947320-53B4-4DC1-B082-BBCD669DF352Q35894666-E6BDAE08-A70C-4277-9061-21746C943EBDQ35945416-008E81A2-82DF-446F-8146-FC30CF0736DE
P2860
Systemic effects of inflammation on health during chronic HIV infection
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Systemic effects of inflammation on health during chronic HIV infection
@ast
Systemic effects of inflammation on health during chronic HIV infection
@en
Systemic effects of inflammation on health during chronic HIV infection.
@nl
type
label
Systemic effects of inflammation on health during chronic HIV infection
@ast
Systemic effects of inflammation on health during chronic HIV infection
@en
Systemic effects of inflammation on health during chronic HIV infection.
@nl
prefLabel
Systemic effects of inflammation on health during chronic HIV infection
@ast
Systemic effects of inflammation on health during chronic HIV infection
@en
Systemic effects of inflammation on health during chronic HIV infection.
@nl
P2860
P1433
P1476
Systemic effects of inflammation on health during chronic HIV infection
@en
P2093
Daniel C Douek
Russell Tracy
P2860
P304
P356
10.1016/J.IMMUNI.2013.10.001
P407
P577
2013-10-01T00:00:00Z